Imifoplatin for peripheral nervous system diseases

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 3 Nov 2021: Trial registered, NCT05104736
  2. 6 Apr 2022: Trial started, NCT05104736

The trials

NCT05104736: PT-112 in Subjects With Thymoma and Thymic Carcinoma

State
Under way
Phase
Phase 2
People
53 planned
Started
6 Apr 2022
Primary completion
31 Dec 2027
Arms
PT-112
Results
None posted
  1. 3 Nov 2021: Trial registered
  2. 6 Apr 2022: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.